Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Cell Biochem. 2019 Dec;120(12):19691-19698. doi: 10.1002/jcb.29275. Epub 2019 Jul 11.
microRNAs (miRNAs) play a critical role in implantation and development of mouse embryos. In this study, we aim to evaluate the possibility of miRNAs as potential biomarkers in the blastocyst culture to assess embryo quality. We also intend to investigate whether improved clinical outcomes of vitrified embryos agree with altered miRNA expressions. Mouse embryos from in vitro fertilization were vitrified at the two-cell stage. After thawing, the embryos were individually cultured and developed to the blastocyst stage. We used quantitative real-time polymerase chain reaction to evaluate miRNA expression levels in both vitrified and fresh groups, and culture medium (CM). The fibronectin binding assay was performed to examine for blastocyst attachment. The findings showed reduced expressions of miR-16-1 (0.2 ± 0.06) and miR-Let-7a (0.65 ± 0.1) after vitrification compared to fresh embryos. We observed significant upregulation of the target genes Vav3 (4.33 ± 0.25), integrin β-3 (Itg β3; 4.73 ± 0.2), and Bcl2 (2.29 ± 0.16) in the vitrified embryos compared to the fresh groups. Evaluation of blastocyst CM showed upregulation of miR-Let-7a (15.68 ± 0.89), miR-16-1 (16.18 ± 0.75), and miR-15a (13.36 ± 0.73) in the vitrified group in comparison to the fresh blastocysts (P < .05). The expression levels of miR-16-1 (3.28 ± 0.63), miR-15a (5.91 ± 0.38), and miR-Let-7a (9.07 ± 0.6) in CM of the vitrified blastocysts conducted on fibronectin were significantly higher than the fresh group (P < .05).This study showed that vitrification of embryos changes implantation and proliferation biomarkers. In addition, upregulated miRNAs in CM could be potentially used for noninvasive early assessment of embryo quality.
微小 RNA(miRNA)在小鼠胚胎着床和发育中发挥着关键作用。本研究旨在评估 miRNA 作为囊胚培养中潜在生物标志物评估胚胎质量的可能性。我们还旨在研究玻璃化胚胎的临床结局改善是否与 miRNA 表达的改变一致。体外受精的小鼠胚胎在二细胞期被玻璃化。解冻后,胚胎单独培养并发育至囊胚阶段。我们使用定量实时聚合酶链反应评估玻璃化和新鲜组以及培养基(CM)中的 miRNA 表达水平。进行纤连蛋白结合测定以检查囊胚附着。结果表明,与新鲜胚胎相比,玻璃化后 miR-16-1(0.2±0.06)和 miR-Let-7a(0.65±0.1)的表达水平降低。我们观察到玻璃化胚胎中靶基因 Vav3(4.33±0.25)、整合素β-3(Itgβ3;4.73±0.2)和 Bcl2(2.29±0.16)的表达显著上调与新鲜组相比。评估囊胚 CM 显示,与新鲜囊胚相比,玻璃化组中 miR-Let-7a(15.68±0.89)、miR-16-1(16.18±0.75)和 miR-15a(13.36±0.73)的表达上调(P<0.05)。玻璃化囊胚 CM 中 miR-16-1(3.28±0.63)、miR-15a(5.91±0.38)和 miR-Let-7a(9.07±0.6)的表达水平明显高于新鲜组(P<0.05)。本研究表明,胚胎的玻璃化改变了着床和增殖的生物标志物。此外,CM 中上调的 miRNA 可用于非侵入性早期评估胚胎质量。